SEC Form 4 · accession 0001209191-18-038962
Orthofix Medical Inc. · OFIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Fujikawa
Officer — President Spine Fixation
Period of report
Jun 20, 2018
Accepted (ET)
Jun 21, 2018 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2018 | M | 10,000 | $22.75 | A | 36,352 | D | |
| Common Stock | Jun 20, 2018 | M | 8,750 | $21.78 | A | 45,102 | D | |
| Common StockF3 | Jun 20, 2018 | S | 28,047 | $60.1622 | D | 17,055 | D | |
| Common StockF4 | Jun 20, 2018 | S | 4,196 | $60.494 | D | 12,859 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $22.75 | Jun 20, 2018 | M | 10,000 | D | Aug 1, 2017 | Aug 1, 2023 | Common Stock | 10,000 | 0 | D |
| Stock Option (right to buy) | $21.78 | Jun 20, 2018 | M | 8,750 | D | Sep 26, 2017 | Sep 26, 2023 | Common Stock | 8,750 | 0 | D |
Explanation of responses
- F1The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
- F2The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.40, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $60.61, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.